<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38981586</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-1797</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nephrology (Carlton, Vic.)</Title><ISOAbbreviation>Nephrology (Carlton)</ISOAbbreviation></Journal><ArticleTitle>Impact of cultural diversity on COVID-19 vaccination hesitancy in kidney transplant recipients.</ArticleTitle><Pagination><StartPage>600</StartPage><EndPage>606</EndPage><MedlinePgn>600-606</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/nep.14351</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To study COVID-19 vaccination status in kidney transplant recipients (KTRs), reasons for incomplete vaccination and the clinical impact of vaccination on patient outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A single-centre retrospective analysis of KTR (n&#x2009;=&#x2009;543) conducted between 1970 and December 2022. Data included baseline demographics, number of vaccinations, reason for incomplete vaccination and patient outcomes following COVID-19 infection. A completed course of COVID-19 vaccination was defined as four or more vaccine doses.</AbstractText><AbstractText Label="EXCLUSION CRITERIA" NlmCategory="METHODS">those deceased prior December 2019, managed by another health service, failed graft, or deceased secondary to non-COVID cause.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">273 of 543 patients met inclusion criteria. Mean age was 58.1&#x2009;&#xb1;&#x2009;12.2&#x2009;years, 66% were male. 58.2% of patients were fully vaccinated, 22.7% received three doses, 7.7% received two doses, 0.7% received one dose, 0.7% received zero doses, and 10% incomplete records. The most common reasons for incomplete vaccination were COVID-19 infection, concern for side effects, and patient unawareness of booster recommendations. Vaccination uptake was greater in Australian born patients compared with those born overseas, odds ratio 0.40 (95% CI 0.23-0.69). KTR with incomplete vaccination had poorer outcomes, higher rate of AKI, long COVID, and increased hospitalization.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The majority of KTR were fully vaccinated. KTR with incomplete vaccination status had poorer outcomes with COVID-19 infection and other issues. Patient education is a major area for improvement targeting patients born overseas and better information regarding side effects. Potential interventions need to address improved communication, cultural relevancy, and language.</AbstractText><CopyrightInformation>&#xa9; 2024 Asian Pacific Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frederick</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0002-3670-2963</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Medicine, St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ierino</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Nephrology, St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Rey</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Medicine, St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodman</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6776-481X</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Nephrology (Carlton)</MedlineTA><NlmUniqueID>9615568</NlmUniqueID><ISSNLinking>1320-5358</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088823" MajorTopicYN="Y">Vaccination Hesitancy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018864" MajorTopicYN="N">Cultural Diversity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066027" MajorTopicYN="N">Transplant Recipients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">kidney transplant</Keyword><Keyword MajorTopicYN="N">patient education</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>10</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38981586</ArticleId><ArticleId IdType="doi">10.1111/nep.14351</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Elias M, Pievani D, Randoux C, et al. COVID&#x2010;19 infection in kidney transplant recipients: disease incidence and clinical outcomes. J Am Soc Nephrol. 2020;31(10):2413&#x2010;2423.</Citation></Reference><Reference><Citation>Caillard S, Chavarot N, Francois H, et al. Is COVID&#x2010;19 infection more severe in kidney transplant recipients? Am J Transplant. 2021;21(3):1295&#x2010;1303.</Citation></Reference><Reference><Citation>Ponticelli C, Campise M. COVID&#x2010;19 vaccination in kidney transplant candidates and recipients. Vaccine. 2022;10(11):1808.</Citation></Reference><Reference><Citation>Kremer D, Pieters TT, Verhaar MC, et al. A systematic review and meta&#x2010;analysis of COVID&#x2010;19 in kidney transplant recipients: lessons to be learned. Am J Transplant. 2021;21(12):3936&#x2010;3945.</Citation></Reference><Reference><Citation>Moreno NF, McAdams R, Goss JA, Galvan NTN. COVID&#x2010;19 vaccine efficacy and immunogenicity in end&#x2010;stage renal disease patients and kidney transplant recipients. Curr Transplant Rep. 2022;9(3):174&#x2010;184.</Citation></Reference><Reference><Citation>Aitken Z, Emerson E, Kavanagh AM. COVID&#x2010;19 vaccination coverage and vaccine hesitancy among Australians with disability and long&#x2010;term health conditions. Health Promot J Austr. 2022;34(4):895&#x2010;902.</Citation></Reference><Reference><Citation>The Transplantation Society of Australia and New Zealand (TSANZ). Updated TSANZ COVID&#x2010;19 vaccination recommendations for transplant recipients. The Transplantation Society of Australia and New Zealand. 2022. Accessed December 1, 2023. https://tsanz.com.au/storage/COVID_Communiques/TSANZ-COVID-19-Vaccination-udpate---17-Jan-2022_Final.pdf</Citation></Reference><Reference><Citation>Australian Technical Advisory Group on Immunisation (ATAGI). COVID&#x2010;19 vaccination statements. The Commonwealth of Australia and Department of Health and Aged Care. Australian Technical Advisory Group on Immunisation (ATAGI). 2023. Accessed December 1, 2023. https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi?language=und</Citation></Reference><Reference><Citation>Muscat DM, Ayre J, Mac O, et al. Psychological, social and financial impacts of COVID&#x2010;19 on culturally and linguistically diverse communities in Sydney, Australia. BMJ Open. 2022;12(5):e058323.</Citation></Reference><Reference><Citation>Carlson SJ, Edwards G, Blyth CC, Nattabi B, Attwell K. &#x2018;Corona is coming&#x2019;: COVID&#x2010;19 vaccination perspectives and experiences amongst culturally and linguistically diverse west Australians. Health Expect. 2022;25:3062&#x2010;3072.</Citation></Reference><Reference><Citation>Tharmaraj D, Dendle C, Polkinghorne KR, Mulley WR. Kidney transplant recipients' attitudes toward COVID&#x2010;19 vaccination and barriers and enablers to vaccine acceptance. Transpl Infect Dis. 2022;24(1):e13749.</Citation></Reference><Reference><Citation>Caillard S, Thaunat O. COVID&#x2010;19 vaccination in kidney transplant recipients. Nat Rev Nephrol. 2021;17(12):785&#x2010;787.</Citation></Reference><Reference><Citation>Oto OA, Ozturk S, Turgutalp K, et al. Predicting the outcome of COVID&#x2010;19 infection in kidney transplant recipients. BMC Nephrol. 2021;22(1):100.</Citation></Reference><Reference><Citation>Sallam M. COVID&#x2010;19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccine. 2021;9(2):160.</Citation></Reference><Reference><Citation>Costantino A, Morlacchi L, Donato MF, et al. Hesitancy toward the full COVID&#x2010;19 vaccination among kidney, liver and lung transplant recipients in Italy. Vaccine. 2022;10(11):1899.</Citation></Reference><Reference><Citation>Ayre J, Muscat DM, Mac O, et al. COVID&#x2010;19 testing and vaccine willingness: cross&#x2010;sectional survey in a culturally diverse community in Sydney, Australia. Health Equity. 2021;6(1):965&#x2010;974.</Citation></Reference><Reference><Citation>Chen T, Li X, Li Q, et al. COVID&#x2010;19 vaccination hesitancy and associated factors among solid organ transplant recipients in China. Hum Vaccin Immunother. 2021;17(12):4999&#x2010;5006.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>